KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Net Cash Flow: 2009-2024

Historic Net Cash Flow for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to -$156.1 million.

  • Idexx Laboratories' Net Cash Flow rose 144.94% to $44.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$101.9 million, marking a year-over-year decrease of 264.52%. This contributed to the annual value of -$156.1 million for FY2024, which is 146.02% down from last year.
  • Latest data reveals that Idexx Laboratories reported Net Cash Flow of -$156.1 million as of FY2024, which was down 146.02% from $339.3 million recorded in FY2023.
  • Over the past 5 years, Idexx Laboratories' Net Cash Flow peaked at $339.3 million during FY2023, and registered a low of -$234.8 million during FY2021.
  • For the 3-year period, Idexx Laboratories' Net Cash Flow averaged around $53.3 million, with its median value being -$23.3 million (2022).
  • Its Net Cash Flow has fluctuated over the past 5 years, first tumbled by 180.90% in 2021, then skyrocketed by 1,555.93% in 2023.
  • Over the past 5 years, Idexx Laboratories' Net Cash Flow (Yearly) stood at $290.3 million in 2020, then crashed by 180.90% to -$234.8 million in 2021, then spiked by 90.08% to -$23.3 million in 2022, then surged by 1,555.93% to $339.3 million in 2023, then plummeted by 146.02% to -$156.1 million in 2024.